Interoception Primes Emotional Processing: Multimodal Evidence from Neurodegeneration

Table 9.

EEG: percentage of rejected trails per conditiona

Variable HCs bvFTD PD AD Statistical results Post hoc
NEG-Intero 25.41 (7.03) 24.60 (9.00) 22.47 (8.94) 20.97 (8.92) F = 1.80,
p = 0.15,
ηp2 = 0.04
HCs-bvFTD: p = 0.98
HCs-PD: p = 0.46
HCs-AD: p = 0.14
NEG-Extero 26.22 (9.14) 23.98 (9.08) 23.28 (12.66) 23.30 (10.03) F = 0.69,
p = 0.55,
ηp2 = 0.01
HCs-bvFTD: p = 0.84 HCs-PD: p = 0.64
HCs-AD: p = 0.66
NEU-Intero 20.06 (9.41) 18.15 (10.68) 20.48 (10.92) 18.48 (12.53) F = 0.28,
p = 0.83,
ηp2 = 0.008
HCs-bvFTD: p = 0.91 HCs-PD: p = 0.99
HCs-AD: p = 0.93
NEU-Extero 24.42 (11.95) 24.12 (13.99) 22.41 (11.53) 19.52 (11.99) F = 0.90,
p = 0.44,
ηp2 = 0.02
HCs-bvFTD: p = 0.99 HCs-PD: p = 0.90
HCs-AD: p = 0.39
  • ↵aData are mean (SD). The percentage of rejected trials was assessed through ANOVAs. Effect sizes were calculated through ηp2. No significant differences were found. All HEP results in HCs and HEP mean difference results were based on a similar amount of trials per emotional valence faces (negative – neutral) and condition (Intero – Extero). NEG, Negative emotion; NEU, Neutral emotion.

  1. The Journal of Neuroscience vol. 41 no. 19 4276-4292
  1. Free Access 
Responses to This Article
Be the first to respond to this article
Advertisement